Cue Health received FDA EUA for Its rapid, portable, molecular point-of-care COVID-19 test
On Jun. 12, 2020, Cue Health announced that it had received Emergency Use Authorization from the U.S. Food…
Biotechnology | CDC | HIV | Therapeutics
The FDA approved drug to treat infants and children with HIV
On Jun. 12, 2020, the U.S. Food and Drug Administration (FDA) approved ViiV Healthcare’s Tivicay (dolutegravir) tablets and…
ViiV Healthcare announced FDA approval of the first-ever dispersible tablet formulation of dolutegravir for children living with HIV
On Jun. 12, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
NIH researchers identified key genomic features that could differentiate SARS-CoV-2 from other coronaviruses that cause less severe disease
On Jun. 11, 2020, a team of researchers from the National Library of Medicine identified genomic features of…
FDA approved Bristol-Myers’ Opdivo’ (nivolumab) for treatment of patients with advanced esophageal squamous cell carcinoma
On Jun. 11, 2020, Bristol-Myers Squibb announced that Opdivo (nivolumab) was approved by the FDA for the treatment…
NIH scientists developed blood test to help improve liver cancer screening
On Jun. 11, 2020, scientists announced the development of a new test that can help identify people who…
Brain cells can harbor and spread HIV virus to the body
On Jun. 11, 2020, researchers have found that astrocytes, a type of brain cell can harbor HIV and…
The FDA approved new therapy for rare disease affecting optic nerve, spinal cord
On Jun. 11, 2020, the FDA approved Viela Bio’s Uplizna (inebilizumab-cdon) injection for intravenous use for the treatment…
Biotechnology | COVID-19 | WHO
WHO reported cluster of COVID-19 in Beijing, China
On Jun. 11, 2020, the World Trade Organizationﾒs (WTO) reported that it was following up with Chinese authorities…
Oldest relative of ragworms and earthworms discovered
On Jun. 11, 2020, scientists at the Universities of Oxford, Exeter, Yunnan and Bristol announced thay had discovered…
Sinovac and Butantan joined efforts to advance clinical development of an inactivated vaccine for COVID-19 to phase III
On Jun. 11, 2020, Sinovac Biotech announced the signing of a clinical development collaboration agreement to advance the…
Emergent BioSolutions signed agreement to be US manufacturing partner for AstraZenecaﾒs COVID-19 vaccine candidate
On Jun. 11, 2020, Emergent BioSolutions announced deployment of its molecule-to-market contract development and manufacturing (CDMO) services to…
Quidel received BARDA funding to develop point-of-care diagnostic assay that includes COVID-19
On Jun. 11, 2020, Quidel announced it had received funding from the Biomedical Advanced Research and Development Authority…
AIM ImmunoTech filed provisional patent application for ose of Ampligen(R) as potential therapy for COVID-19 Induced chronic fatigue
On Jun. 11, 2020, AIM ImmunoTech announced that it had filed a provisional patent application for, among other…
Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19
On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…
Innovation Pharma collaborated with regional biocontainment lab on grant application to research Brilacidin as pan-Coronavirus therapeutic
On Jun. 11, 2020, Innovation Pharma announced the Company and researchers at a U.S. Regional Biocontainment Laboratory (RBL)…
CHF Solutions publication highlights use of ultrafiltration for fluid management in COVID-19 patients
On Jun. 11, 2020, CHF Solutions announced that it has sold Aquadex SmartFlowﾙ consoles and disposables to a…
BioCryst’s galidesivir stops Zika viral replication in primate model
On Jun. 11, 2020, BioCryst Pharmaceuticals announced new data published in Science Translational Medicine that show, in a…
Regeneron began first clinical trials of anti-viral antibody cocktail REGN-COV2 for treatment and prevention of COVID-19
On Jun. 11, 2020, Regeneron announced initiation of the first clinical trial of REGN-COV2, its investigational dual antibody…
Two science publications highlight potential of REGN-COV2 anti-viral antibody cocktail to protect against SARS-CoV-2 escape mutants
On Jun. 11, 2020, Regeneron announced that Science had accepted for publication two papers describing the creation of…
UT Southwestern scientists examined structure of protein involved in Parkinsonﾒs disease, psychosis and addiction
On Jun. 11, 2020, a new study led by UT Southwestern researchers revealed the structure of the active…
Biotechnology | COVID-19 | Diagnostics | FDA
InBios received FDA Emergency Use Authorization for COVID-19 antibody test
On Jun. 11, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the U.S. Food…
Atossa Therapeutics announced availability of manuscript on results from in vitro testing of COVID-19 drug
On Jun. 11, 2020, Atossa Therapeutics announced that the manuscript of the results from in vitro testing of…
COVID-19 | NIH | Therapeutics
NIH funded study to evaluate drugs prescribed to children with COVID-19
On Jun. 10, 2020, researchers funded by the National Institutes of Health (NIH) launched an effort to evaluate…
NIH study linked cigarette smoking to higher stroke risk in African Americans
On Jun. 10, 2020, African Americans who smoke are nearly 2.5 times more likely to have a stroke…
Landmark legal victory for public health and a major setback for the tobacco industry
On Jun. 10, 2020, the World Trade Organizationﾒs (WTO) Appellate Body reported on the dispute brought by Honduras…
The FDA authorized first next generation sequence test for diagnosing COVID-19
On Jun. 10, 2020, the FDA issued an emergency use authorization (EUA) to Illumina for the first COVID-19…
COVID-19 mouse model announced to speed search for drugs, vaccines
On Jun. 10, 2020, Washington University School of Medicine in St. Louis reported they had developed a mouse…
Johnson & Johnson announced acceleration of its COVID-19 vaccine candidate with phase 1/2a clinical trial
On Jun. 10, 2020, Johnson & Johnson announced that through its Janssen Pharmaceutical subsidiary it has accelerated the…
OraSure received BARDA funding for Coronavirus Antibody ELISA using oral fluid samples
On Jun. 10, 2020, OraSure Technologies announced it had been awarded a $629,217 contract from the Biomedical Advanced…